Symbols / BWAY
BWAY Chart
About
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 489.13M |
| Enterprise Value | 891.95M | Income | 6.25M | Sales | 49.09M |
| Book/sh | 1.79 | Cash/sh | 1.80 | Dividend Yield | — |
| Payout | 0.00% | Employees | 120 | IPO | — |
| P/E | 75.66 | Forward P/E | 88.57 | PEG | — |
| P/S | 9.96 | P/B | 13.53 | P/C | — |
| EV/EBITDA | 209.92 | EV/Sales | 18.17 | Quick Ratio | 2.91 |
| Current Ratio | 3.19 | Debt/Eq | 9.64 | LT Debt/Eq | — |
| EPS (ttm) | 0.32 | EPS next Y | 0.27 | EPS Growth | 100.00% |
| Revenue Growth | 28.70% | Earnings | 2026-03-11 | ROA | 1.92% |
| ROE | 10.95% | ROIC | — | Gross Margin | 74.92% |
| Oper. Margin | 9.27% | Profit Margin | 12.73% | Shs Outstand | 19.61M |
| Shs Float | 24.75M | Short Float | 0.71% | Short Ratio | 0.71 |
| Short Interest | — | 52W High | 26.63 | 52W Low | 7.84 |
| Beta | 0.32 | Avg Volume | 95.73K | Volume | 11.78K |
| Target Price | $26.33 | Recom | Strong_buy | Prev Close | $24.41 |
| Price | $24.21 | Change | -0.82% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-26 | main | HC Wainwright & Co. | Buy → Buy | $30 |
| 2025-12-08 | main | HC Wainwright & Co. | Buy → Buy | $24 |
| 2025-11-13 | main | HC Wainwright & Co. | Buy → Buy | $18 |
| 2025-11-12 | main | Northland Capital Markets | Outperform → Outperform | $23 |
| 2025-08-25 | reit | HC Wainwright & Co. | Buy → Buy | $17 |
| 2025-08-14 | main | Northland Capital Markets | Outperform → Outperform | $19 |
| 2025-08-14 | main | HC Wainwright & Co. | Buy → Buy | $17 |
| 2025-06-12 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2025-06-09 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2025-03-12 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-12-23 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-10-21 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-10-03 | main | Northland Capital Markets | Outperform → Outperform | $13 |
| 2024-09-16 | reit | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-08-08 | main | HC Wainwright & Co. | Buy → Buy | $16 |
| 2024-08-07 | main | Northland Capital Markets | Outperform → Outperform | $11 |
| 2024-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $15 |
| 2024-05-09 | main | Oppenheimer | Outperform → Outperform | $11 |
| 2024-05-09 | main | HC Wainwright & Co. | Buy → Buy | $15 |
| 2024-03-11 | main | HC Wainwright & Co. | Buy → Buy | $13 |
- Surging Earnings Estimates Signal Upside for Brainsway (BWAY) Stock - Nasdaq Mon, 18 Aug 2025 07
- Brainsway Stock Set to Split on Tuesday, March 3rd (NASDAQ:BWAY) - MarketBeat hu, 19 Feb 2026 06
- Blue Cross insurer eyes 6‑day brain stimulation plan for depression - Stock Titan Wed, 21 Jan 2026 08
- BWAY Shares Gain on Optum Expanding Deep TMS Coverage for Teens - Yahoo Finance ue, 23 Dec 2025 08
- Trading Systems Reacting to (BWAY) Volatility - Stock Traders Daily Wed, 18 Feb 2026 06
- What Analysts Are Saying About BrainsWay Stock - BrainsWay (NASDAQ:BWAY) - Benzinga Mon, 26 Jan 2026 08
- BrainsWay: High Growth Set To Persist (NASDAQ:BWAY) - Seeking Alpha hu, 13 Nov 2025 08
- BrainsWay to Implement 1-for-1 ADS-to-Ordinary Share Ratio in March 2026 - TipRanks ue, 17 Feb 2026 13
- BWAY Shares Rise on Strategic Investment in Neurolief's At-Home Care - Zacks Investment Research Fri, 22 Aug 2025 07
- BrainsWay Stock Reaches All-Time High, Revenue Growth Expected To Soar By 22%-27% In FY2025 - RTTNews Wed, 17 Sep 2025 07
- Is BWAY stock near bottom after decline - July 2025 Opening Moves & Weekly Stock Breakout Alerts - mfd.ru Fri, 20 Feb 2026 21
- Brainsway (NASDAQ:BWAY) Reaches New 12-Month High - What's Next? - MarketBeat Wed, 18 Feb 2026 18
- Major insurer adds non-drug depression treatment option for teens 15 and up - Stock Titan Mon, 22 Dec 2025 08
- How Brainsway Ltd. (BWAY) Affects Rotational Strategy Timing - Stock Traders Daily Sat, 07 Feb 2026 08
- What To Expect From BrainsWay Ltd (BWAY) Q3 2025 Earnings - Yahoo Finance Mon, 10 Nov 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 147.29K | -65.32K | -56.12K | -76.59K |
| TaxRateForCalcs | 0.16 | 0.23 | 0.23 | 0.23 |
| NormalizedEBITDA | 4.41M | -2.28M | -11.21M | -4.34M |
| TotalUnusualItems | 947.00K | -284.00K | -244.00K | -333.00K |
| TotalUnusualItemsExcludingGoodwill | 947.00K | -284.00K | -244.00K | -333.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | 2.92M | -4.20M | -13.35M | -6.46M |
| ReconciledDepreciation | 1.77M | 1.34M | 1.53M | 1.69M |
| ReconciledCostOfRevenue | 9.06M | 7.25M | 6.05M | 5.38M |
| EBITDA | 5.36M | -2.56M | -11.45M | -4.67M |
| EBIT | 3.59M | -3.90M | -12.99M | -6.36M |
| NetInterestIncome | 1.12M | 1.30M | -107.00K | -1.09M |
| InterestExpense | 127.00K | 48.00K | 46.00K | 60.00K |
| InterestIncome | 2.48M | 2.17M | 1.11M | 225.00K |
| NormalizedIncome | 2.12M | -3.98M | -13.16M | -6.21M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 2.92M | -4.20M | -13.35M | -6.46M |
| TotalExpenses | 39.62M | 36.74M | 39.86M | 34.66M |
| RentExpenseSupplemental | 2.20M | 3.09M | ||
| TotalOperatingIncomeAsReported | 1.39M | -4.96M | -12.68M | 5.00M |
| DilutedAverageShares | 16.23M | 16.14M | 16.69M | 15.39M |
| BasicAverageShares | 16.23M | 16.14M | 16.69M | 15.39M |
| DilutedEPS | 0.18 | -0.26 | -0.80 | -0.42 |
| BasicEPS | 0.18 | -0.26 | -0.80 | -0.42 |
| DilutedNIAvailtoComStockholders | 2.92M | -4.20M | -13.35M | -6.46M |
| NetIncomeCommonStockholders | 2.92M | -4.20M | -13.35M | -6.46M |
| NetIncome | 2.92M | -4.20M | -13.35M | -6.46M |
| NetIncomeIncludingNoncontrollingInterests | 2.92M | -4.20M | -13.35M | -6.46M |
| NetIncomeContinuousOperations | 2.92M | -4.20M | -13.35M | -6.46M |
| TaxProvision | 538.00K | 251.00K | 315.00K | 43.00K |
| PretaxIncome | 3.46M | -3.95M | -13.03M | -6.42M |
| OtherIncomeExpense | 947.00K | -284.00K | -244.00K | -333.00K |
| GainOnSaleOfSecurity | 947.00K | -284.00K | -244.00K | -333.00K |
| NetNonOperatingInterestIncomeExpense | 1.12M | 1.30M | -107.00K | -1.09M |
| TotalOtherFinanceCost | 1.23M | 826.00K | 1.17M | 1.25M |
| InterestExpenseNonOperating | 127.00K | 48.00K | 46.00K | 60.00K |
| InterestIncomeNonOperating | 2.48M | 2.17M | 1.11M | 225.00K |
| OperatingIncome | 1.39M | -4.96M | -12.68M | -5.00M |
| OperatingExpense | 29.19M | 28.44M | 32.73M | 28.06M |
| ProvisionForDoubtfulAccounts | 570.00K | -145.00K | 281.00K | 323.00K |
| DepreciationAmortizationDepletionIncomeStatement | 399.00K | 278.00K | 455.00K | 471.00K |
| DepreciationAndAmortizationInIncomeStatement | 399.00K | 278.00K | 455.00K | 471.00K |
| DepreciationIncomeStatement | 399.00K | 278.00K | 455.00K | 471.00K |
| ResearchAndDevelopment | 7.19M | 6.67M | 7.68M | 6.39M |
| SellingGeneralAndAdministration | 21.03M | 21.64M | 24.32M | 20.87M |
| SellingAndMarketingExpense | 6.79M | 5.92M | 7.30M | 6.23M |
| GeneralAndAdministrativeExpense | 14.24M | 15.72M | 17.02M | 14.64M |
| OtherGandA | 2.05M | 2.65M | 3.32M | 2.04M |
| SalariesAndWages | 12.19M | 13.06M | 13.69M | 12.60M |
| GrossProfit | 30.58M | 23.48M | 20.05M | 23.06M |
| CostOfRevenue | 10.44M | 8.31M | 7.13M | 6.60M |
| TotalRevenue | 41.02M | 31.79M | 27.18M | 29.66M |
| OperatingRevenue | 41.02M | 31.79M | 27.18M | 29.66M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 37.63M | 33.24M | 33.05M | 32.91M |
| ShareIssued | 37.63M | 33.24M | 33.05M | 32.91M |
| TotalDebt | 5.62M | 471.00K | 488.00K | 754.00K |
| TangibleBookValue | 62.31M | 41.58M | 45.40M | 57.33M |
| InvestedCapital | 62.31M | 41.58M | 45.40M | 57.33M |
| WorkingCapital | 64.32M | 45.70M | 49.95M | 56.38M |
| NetTangibleAssets | 62.31M | 41.58M | 45.40M | 57.33M |
| CapitalLeaseObligations | 5.62M | 471.00K | 488.00K | 754.00K |
| CommonStockEquity | 62.31M | 41.58M | 45.40M | 57.33M |
| TotalCapitalization | 62.31M | 41.58M | 45.40M | 57.33M |
| TotalEquityGrossMinorityInterest | 62.31M | 41.58M | 45.40M | 57.33M |
| StockholdersEquity | 62.31M | 41.58M | 45.40M | 57.33M |
| OtherEquityInterest | 4.87M | 4.36M | 6.18M | 5.34M |
| GainsLossesNotAffectingRetainedEarnings | -2.19M | -2.19M | -2.19M | -2.19M |
| OtherEquityAdjustments | 5.34M | |||
| ForeignCurrencyTranslationAdjustments | -2.19M | -2.19M | -2.19M | -2.19M |
| RetainedEarnings | -98.38M | -101.30M | -97.11M | -83.76M |
| AdditionalPaidInCapital | 157.60M | 140.34M | 138.15M | 137.57M |
| CapitalStock | 413.00K | 367.00K | 364.00K | 363.00K |
| CommonStock | 413.00K | 367.00K | 364.00K | 363.00K |
| TotalLiabilitiesNetMinorityInterest | 32.00M | 21.39M | 19.08M | 18.41M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 16.66M | 11.63M | 10.94M | 9.34M |
| OtherNonCurrentLiabilities | 6.08M | 6.02M | 5.93M | |
| DerivativeProductLiabilities | 2.43M | 0.00 | ||
| NonCurrentDeferredLiabilities | 9.43M | 11.39M | 4.67M | 3.16M |
| NonCurrentDeferredRevenue | 9.43M | 11.39M | 4.67M | 3.16M |
| LongTermDebtAndCapitalLeaseObligation | 4.80M | 239.00K | 254.00K | 254.00K |
| LongTermCapitalLeaseObligation | 4.80M | 239.00K | 254.00K | 254.00K |
| CurrentLiabilities | 15.35M | 9.76M | 8.14M | 9.07M |
| OtherCurrentLiabilities | 1.01M | 1.06M | 978.00K | |
| CurrentDeferredLiabilities | 5.73M | 3.51M | 1.48M | 2.19M |
| CurrentDeferredRevenue | 5.73M | 3.51M | 1.48M | 2.19M |
| CurrentDebtAndCapitalLeaseObligation | 824.00K | 232.00K | 234.00K | 500.00K |
| CurrentCapitalLeaseObligation | 824.00K | 232.00K | 234.00K | 500.00K |
| PensionandOtherPostRetirementBenefitPlansCurrent | 2.72M | 2.06M | 1.87M | 1.14M |
| PayablesAndAccruedExpenses | 6.07M | 3.95M | 3.50M | 4.25M |
| CurrentAccruedExpenses | 2.58M | 2.48M | 2.31M | 2.90M |
| Payables | 3.50M | 1.47M | 1.20M | 1.36M |
| OtherPayable | 250.00K | 153.00K | ||
| DuetoRelatedPartiesCurrent | 109.00K | 57.00K | 80.00K | 236.00K |
| TotalTaxPayable | 268.00K | 504.00K | 0.00 | 18.00K |
| IncomeTaxPayable | 268.00K | 504.00K | ||
| AccountsPayable | 2.87M | 758.00K | 1.12M | 1.10M |
| TotalAssets | 94.32M | 62.97M | 64.48M | 75.73M |
| TotalNonCurrentAssets | 14.65M | 7.51M | 6.39M | 10.29M |
| OtherNonCurrentAssets | 1.04M | 954.00K | ||
| NonCurrentPrepaidAssets | 1.64M | 889.00K | 766.00K | |
| NonCurrentDeferredAssets | 1.06M | 828.00K | 276.00K | |
| NonCurrentDeferredTaxesAssets | 1.06M | 828.00K | 276.00K | |
| NetPPE | 11.95M | 5.79M | 5.35M | 9.33M |
| AccumulatedDepreciation | -6.13M | -6.29M | -5.50M | -5.60M |
| GrossPPE | 18.08M | 12.09M | 10.84M | 14.94M |
| Leases | 394.00K | 102.00K | 81.00K | 69.00K |
| OtherProperties | 9.89M | 9.77M | 9.26M | 13.56M |
| MachineryFurnitureEquipment | 2.51M | 1.92M | 1.50M | 1.30M |
| BuildingsAndImprovements | 5.29M | 296.00K | ||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 79.67M | 55.47M | 58.09M | 65.45M |
| OtherCurrentAssets | 1.03M | 1.71M | 1.56M | 1.57M |
| RestrictedCash | 271.00K | 271.00K | 271.00K | |
| PrepaidAssets | 1.18M | |||
| Inventory | 4.43M | 3.72M | 3.84M | 200.00K |
| InventoriesAdjustmentsAllowances | -1.15M | -1.12M | -1.61M | |
| OtherInventories | 3.84M | |||
| FinishedGoods | 2.57M | 1.83M | 1.23M | |
| WorkInProcess | 208.00K | 1.21M | 1.65M | |
| RawMaterials | 2.79M | 1.79M | 2.56M | 200.00K |
| Receivables | 4.60M | 3.78M | 4.84M | 6.33M |
| OtherReceivables | 606.00K | 388.00K | ||
| AccountsReceivable | 4.60M | 3.78M | 4.84M | 6.33M |
| AllowanceForDoubtfulAccountsReceivable | -1.16M | -904.00K | -1.10M | -1.26M |
| GrossAccountsReceivable | 5.76M | 4.68M | 5.95M | 7.59M |
| CashCashEquivalentsAndShortTermInvestments | 69.34M | 45.98M | 47.58M | 57.35M |
| OtherShortTermInvestments | 0.00 | 35.47M | 0.00 | 40.43M |
| CashAndCashEquivalents | 69.34M | 10.52M | 47.58M | 16.92M |
| CashEquivalents | 55.28M | 0.00 | 40.27M | 1.45M |
| CashFinancial | 14.07M | 10.52M | 7.31M | 15.47M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 6.50M | -1.10M | -9.76M | -1.35M |
| RepurchaseOfCapitalStock | 0.00 | 0.00 | -52.00K | |
| RepaymentOfDebt | -424.00K | -271.00K | -533.00K | -475.00K |
| IssuanceOfCapitalStock | 16.35M | 0.00 | 0.00 | 42.26M |
| CapitalExpenditure | -3.79M | -2.39M | -2.24M | |
| EndCashPosition | 69.34M | 10.52M | 47.58M | 16.92M |
| BeginningCashPosition | 10.52M | 47.58M | 16.92M | 16.96M |
| EffectOfExchangeRateChanges | -47.00K | 90.00K | -202.00K | -224.00K |
| ChangesInCash | 58.87M | -37.15M | 30.86M | 184.00K |
| FinancingCashFlow | 18.26M | -1.03M | -1.55M | 41.52M |
| CashFlowFromContinuingFinancingActivities | 18.26M | -1.03M | -1.55M | 41.52M |
| NetOtherFinancingCharges | -1.11M | -755.00K | -962.00K | -269.00K |
| ProceedsFromStockOptionExercised | 3.44M | 0.00 | 0.00 | |
| NetCommonStockIssuance | 16.35M | 0.00 | -52.00K | 42.26M |
| CommonStockPayments | 0.00 | 0.00 | -52.00K | |
| CommonStockIssuance | 16.35M | 0.00 | 0.00 | 42.26M |
| NetIssuancePaymentsOfDebt | -424.00K | -271.00K | -533.00K | -475.00K |
| NetLongTermDebtIssuance | -424.00K | -271.00K | -533.00K | -475.00K |
| LongTermDebtPayments | -424.00K | -271.00K | -533.00K | -475.00K |
| InvestingCashFlow | 30.31M | -37.41M | 42.17M | -42.22M |
| CashFlowFromContinuingInvestingActivities | 30.31M | -37.41M | 42.17M | -42.22M |
| NetOtherInvestingChanges | 76.00K | |||
| NetInvestmentPurchaseAndSale | 34.03M | -35.02M | 40.23M | -39.98M |
| SaleOfInvestment | 35.00M | 0.00 | 40.25M | 22.00K |
| PurchaseOfInvestment | -971.00K | -35.02M | -21.00K | -40.00M |
| NetPPEPurchaseAndSale | -3.79M | -2.39M | 1.94M | -2.24M |
| PurchaseOfPPE | -2.24M | |||
| OperatingCashFlow | 10.30M | 1.28M | -9.76M | 884.00K |
| CashFlowFromContinuingOperatingActivities | 10.30M | 1.28M | -9.76M | 884.00K |
| TaxesRefundPaid | -1.01M | -11.00K | -443.00K | -14.00K |
| InterestReceivedCFO | 2.92M | 1.71M | 1.04M | 17.00K |
| InterestPaidCFO | -124.00K | -253.00K | -46.00K | -62.00K |
| ChangeInWorkingCapital | 2.39M | 1.64M | -1.45M | 1.07M |
| ChangeInOtherWorkingCapital | 277.00K | 1.63M | 790.00K | 2.04M |
| ChangeInOtherCurrentAssets | 1.65M | -312.00K | -403.00K | -1.23M |
| ChangeInPayablesAndAccruedExpense | 2.25M | -265.00K | 298.00K | 1.10M |
| ChangeInPayable | 2.25M | -265.00K | 298.00K | 1.10M |
| ChangeInAccountPayable | 2.12M | -327.00K | 0.00 | 289.00K |
| ChangeInInventory | -920.00K | -506.00K | -3.60M | 0.00 |
| ChangeInReceivables | -867.00K | 1.09M | 1.46M | -849.00K |
| ChangesInAccountReceivables | -867.00K | 1.09M | 1.46M | -849.00K |
| OtherNonCashItems | -2.07M | -1.01M | 351.00K | 1.42M |
| StockBasedCompensation | 1.44M | 381.00K | 1.47M | 1.89M |
| AssetImpairmentCharge | 1.52M | 1.45M | 816.00K | 1.29M |
| DeferredTax | 538.00K | 251.00K | 315.00K | 43.00K |
| DeferredIncomeTax | 538.00K | 251.00K | 315.00K | 43.00K |
| DepreciationAmortizationDepletion | 1.77M | 1.34M | 1.53M | 1.69M |
| DepreciationAndAmortization | 1.77M | 1.34M | 1.53M | 1.69M |
| Depreciation | 1.77M | 1.34M | 1.53M | 1.69M |
| NetIncomeFromContinuingOperations | 2.92M | -4.20M | -13.35M | -6.46M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for BWAY
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|